Stockscreener 앱 받기
0.655
5.35%
-0.037
시장 영업 전:
.67
0.015
+2.29%
전일 마감가:
$0.692
열려 있는:
$0.6991
하루 거래량:
217.85K
Relative Volume:
0.05
시가총액:
$2.89M
수익:
$75,000
순이익/손실:
$-40.08M
주가수익비율:
-0.00338
EPS:
-193.9456
순현금흐름:
$-16.26M
1주 성능:
-9.68%
1개월 성능:
+24.29%
6개월 성능:
-97.29%
1년 성능:
+0.00%
1일 변동 폭
$0.6401
$0.6991
1주일 범위
$0.62
$0.7201
52주 변동 폭
$0.4101
$166.50
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.655 | 3.05M | 75,000 | -40.08M | -16.26M | -193.95 |
ABT
Abbott Laboratories
|
96.00 | 166.82B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 129.58B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 109.13B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 90.64B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.95B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profusa Inc 주식(PFSA)의 최신 뉴스
What's going on with Profusa stock Tuesday? - MSN
Profusa’s Next-Generation Biosensor Technology: Real-Time Biochemistry Monitoring for Chronic Disease Management and Telemedicine Applications - Minichart
Profusa, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profusa (NASDAQ: PFSA) outlines Lumee biosensor pipeline, funding and 1-for-75 reverse split - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why did PFSA stock surge 80% pre-market today? - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Crude Oil Gains 3%; Alignment Healthcare Shares Jump - Sahm
Dow Falls 200 Points; US Durable Goods Orders Decline In February - Sahm
Gold Edges Higher; ISM Services PMI Falls In March - Sahm
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
What's Going On With Profusa Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Profusa expands into precision diagnostics market - Medical Buyer
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - bitget.com
Profusa to acquire multi-omics platform, partners with Mayo Clinic By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Monday's session: top gainers and losers - ChartMill
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Curious about the most active stocks on Monday? - ChartMill
Profusa shares surge after $30M PanOmics acquisition LOI signals pivot into molecular diagnostics - Quiver Quantitative
Profusa (PFSA) Stock Soars 173% on $30M PanOmics Diagnostics Acquisition - Blockonomi
US Stocks Mixed; Nasdaq Gains Over 100 Points - Benzinga
Profusa (PFSA) Stock Rockets 173% After $30M Oncology Platform Deal - CoinCentral
Profusa’s Strategic Meeting Sparks Investment Talks - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Is Profusa Stock Soaring Monday?Profusa (NASDAQ:PFSA) - Benzinga
Profusa Inc. Signs $30 Million Non-Binding LOI to Acquire PanOmics Assets from Bio Insights LLC - Minichart
Profusa expands into multi-billion dollar precision diagnostics market with $30m letter of intent for a PanOmics platform - marketscreener.com
Profusa Expands Convertible Note Capacity to $12.22 Million, Issues $555,555 12% Note - TradingView
Profusa to acquire multi-omics platform, partners with Mayo Clinic - investing.com
Profusa (Nasdaq: PFSA) signs $30M PanOmics diagnostics LOI - Stock Titan
$Profusa (PFSA.US)$ tap in and out for a quick scalp - Moomoo
Profusa Expands into Multi-Billion Dollar Precision - GlobeNewswire
Trending Stocks Today | Profusa Soars 126.91% Pre-Market - Moomoo
Profusa, Inc. entered into a non-binding letter of intent to acquire Certain assets of Bio Insights LLC from Bio Insights LLC for $30 million. - marketscreener.com
PFSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
NVACW SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Delays Annual Report Amid Wider Losses - TipRanks
Profusa (NVACW) delays 2025 Form 10-K; $31.9M loss after merger - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PFSA Should I Buy - Intellectia AI
Profusa Incenters amendment to promissory note with Northview Sponsor I LLC on March 20, 2026SEC filing - marketscreener.com
Profusa Extends Promissory Note Maturity, Enhancing Liquidity - TipRanks
Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
Profusa Inc (PFSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):